FIB4 usefulness for measuring fibrosis changes following anti-HCV - Viral treatment

被引：0
|
作者：
Nalpas, Bertrand
Fontaine, Helene
Vallet-Pichard, Anais
Mallet, Vincent
Verkarre, Virginie
Pol, Stanislas
机构：
[1] Hop Cochin, Liver Unit, Paris, France
[2] Hop Cochin, INSERM, U567, F-75674 Paris, France
[3] Hop Necker Enfants Malad, Serv Anat Pathol, Paris, France
来源：
HEPATOLOGY | 2007年 / 46卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1357
引用
收藏
页码：842A / 843A
页数：2
相关论文
共 32 条
  • [31] Hepatitis C Virus (HCV)-Infected Patients Receiving Opioid Substitution Therapy (OST) Experience Significant Increases in Patient-Reported Outcomes (PROs) Following Treatment with Anti-Viral Regimens
    Stepanova, Maria
    Thompson, Alex J.
    Doyle, Joseph S.
    de Avila, Leyla
    Younossi, Issah
    Henry, Linda
    Younossi, Zobair M.
    HEPATOLOGY, 2017, 66 : 330A - 330A
  • [32] Patterns of liver fibrosis evolution in Chinese HIV/HBV co-infected adults following 5-year antiretroviral treatment: A longitudinal study using non-invasive APRI and Fib-4 scores
    Zhang, Qingrong
    Sun, Lijun
    Liang, Yuxuan
    Zou, Wenlu
    Huang, Jingtao
    Zhang, Yuan
    Jin, Yi
    Zhou, Na
    Ye, Jiangzhu
    Zou, Huachun
    Wu, Hao
    Zhang, Tong
    Su, Bin
    Jiang, Taiyi
    Chen, Haitao
    VIROLOGICA SINICA, 2025, 40 (01) : 118 - 124
1234